A carregar...
Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
CD19 Chimeric antigen receptor (CAR) T cell therapy has been shown to be effective for B cell leukemia and lymphoma. Many researchers are now trying to develop CAR T cells for various types of cancer. For multiple myeloma (MM), B-cell maturation antigen (BCMA) has been recently proved to be a promis...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6966463/ https://ncbi.nlm.nih.gov/pubmed/31847470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11122024 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|